UNSPSC 85291802: Diagnosis of epiphora

This classification denotes the group of activities that yields a diagnosis of Epiphora. Epiphora is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code H04. 2

UNSPSC 85291802 Diagnosis of epiphora is a Commodity code, but the recent state and local opportunities posted under it show a significant mismatch between the code's nominal scope—ophthalmologic diagnosis of excessive tearing—and the work actually being solicited. The three identified opportunities span diagnostic imaging systems (PACS infrastructure), ultrasound equipment procurement, and phlebotomy blood draw services; none involve epiphora diagnosis or related ophthalmologic work. This suggests either systematic miscoding by the issuing bodies or that the code's use in state and local procurement does not reflect its UNSPSC definition. Issuing bodies include a county health authority (San Mateo Medical Center), a county procurement division (Collier County, Florida), and a municipal police department (Albuquerque Police Department). The opportunities reflect capital equipment buys, single-source procurements, and on-call service contracts rather than a coherent commodity family.

Geographic activity centers on California (San Mateo County), Florida (Collier County), and New Mexico (Albuquerque), with no clear pattern of repeat buyers or regional concentration under this code. Representative recent opportunities include San Mateo Medical Center's RFP for enterprise-grade diagnostic imaging PACS with EPIC integration, due August 7, 2026, supporting radiology, cardiology, and dental imaging across 65,000 annual studies with 5% to 10% local preference; Collier County's Notice of Intent to single-source EchoNous ultrasound equipment and a five-year warranty, with a submission deadline that has already passed (March 26, 2026); and the Albuquerque Police Department's RFB for on-call phlebotomy services with 300 anticipated annual calls, due February 25, 2026. Business development professionals should verify code assignment with issuing bodies before pursuing opportunities under this code, as the recent activity does not support focused market development in epiphora-related diagnostics.